The Covid 19 pandemic has highlighted the great potential in terms of development speed and reduced time-to-market for vaccines that can be unlocked through tremendous government and private efforts. Now, the biopharmaceutical industry faces the challenge of adapting its cyber-physical production systems (CPPS) to provide its customers with comparable time-to-market at lower expenditures during non-crisis periods. Given the importance of this industry, it is important to address their specific automation needs to ensure robust and efficient biopharmaceutical production in the future. In this paper, we combine a modified page rank algorithm, with traditional scenario technique, to describe and analyze future scenarios for technological development in the biopharmaceutical industry. Then, a forward-looking Strengths-Weaknesses-Opportunities-Threats analysis (SWOT analysis) is applied to these scenarios to identify future potentials and challenges in this industry. Finally, in response to these future challenges and opportunities, we propose a set of automation architecture requirements that should underlie future cyber-physical production systems in the biopharmaceutical industry.